Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial.

ABSTRACT:

Background

Although prostate cancer is the most common cancer among veterans receiving care in the Veterans Health Administration (VA), more needs to be done to understand and improve survivorship care for this large population. This study, funded by VA Health Services Research & Development (HSR&D), seeks to address the need to improve patient-centered survivorship care for veterans with prostate cancer.

Methods/design

This is a two-armed randomized controlled trial (RCT) with a target enrollment of up to 325 prostate cancer survivors per study arm (total anticipated n = 600). Patients will be recruited from four VA sites. Patient eligibility criteria include age range of 40-80 years, one to ten years post-treatment, and currently experiencing prostate cancer symptom burden

SUBMITTER: Skolarus TA 

PROVIDER: S-EPMC5395886 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature